A diverse stochastic search algorithm for combination therapeutics

Mehmet Umut Caglar1, Ranadip Pal2

  • 1Department of Physics, Texas Tech University, P.O. Box 41051, Lubbock, TX 79409, USA ; Department of Electrical and Computer Engineering, Texas Tech University, P.O. Box 43102, Lubbock, TX 79409, USA.

Abstract

Insights

Designing optimal drug combinations requires minimizing experiments. A new stochastic search algorithm significantly reduces experimental iterations for personalized drug cocktails, improving efficiency in drug discovery.

Area of Science:

  • Computational biology
  • Pharmacology
  • Bioinformatics

Background:

  • Designing effective drug combination cocktails for individual patients is challenging due to the vast number of potential combinations and patient-specific genetic variations.
  • Exhaustive experimental approaches are infeasible, and existing methods struggle to incorporate personalized genetic data for optimization.

Purpose of the Study:

  • To develop an efficient algorithm for optimizing drug combination cocktails.
  • To minimize the number of experiments required for identifying effective drug combinations for personalized medicine.

Main Methods:

  • A novel stochastic search algorithm combining parallel experimentation with focused and diversified sequential search.
  • Evaluation on synthetic datasets and biological examples, including bacterial and lung cancer cell inhibition responses.

Main Results:

  • The proposed algorithm demonstrated superior performance compared to a recently proposed adaptive reference update approach.
  • Achieved an average reduction of 45% in experimental iterations across all tested examples.
  • Successfully optimized drug combinations for bacterial and lung cancer cell inhibition.

Conclusions:

  • The diverse stochastic search algorithm efficiently identifies optimized drug combinations in fewer iterative steps.
  • This approach is amenable to integration with patient genetic data for designing personalized drug cocktails.
  • Offers a promising strategy for accelerating drug discovery and development in personalized medicine.

Related Concept Videos

Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

1.5K
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K
Drug Discovery: Overview01:26

Drug Discovery: Overview

Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
10.4K
Combined Effects of Drugs: Synergism01:27

Combined Effects of Drugs: Synergism

Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
6.2K
Structure-Activity Relationships and Drug Design01:28

Structure-Activity Relationships and Drug Design

Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
1.9K
Pharmacodynamic Models: Additive and Proportional Drug Effect Model01:09

Pharmacodynamic Models: Additive and Proportional Drug Effect Model

Drug response models describe how pharmacological agents interact with biological systems to produce measurable effects. Baseline responses are inherent physiological activities without a drug significantly influencing the observed pharmacological outcomes. Depending on the drug response model employed, these baseline responses may combine with the drug's effect in either an additive or proportional manner.Additive Drug Response ModelIn the additive model, the drug effect is independent of the...
119